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A 25-year trend in gastrointestinal cancers in northern 
Iran (1991-2016) 
 
Abstract 
Background: Identifying the incidence of cancer helps in planning and prioritizing 
resources for its screening, prevention, treatment and diagnosis. This study aimed at 
investigating a 25-year trend in gastrointestinal cancer in northern Iran during 1991-2016. 
Methods: This research was a trend analysis. The study population was one thousand five 
hundred and thirty-five cancer patients referring to Shahid Rajai Hospital in Babolsar, 
northern Iran, as the only center for radiotherapy in the North of Iran, during 1991-2016. 
SPSS version 22 was used for entering data and t-test, ᵡ2 and ANOVA were used for 
analyzing data in the significant level of ≤0.05. 
Results: The highest incidence of stomach cancer was 111 (35%) in 2011 and the lowest 
incidence was 44 (16.3%) in 1996, The highest frequency of esophageal cancer was 
reported 137(56.1%) cases in 1991 and the lowest frequency was 78 (26.3%) cases in 
2016, while the highest incidence of colorectal cancer was 109 (36.7%) cases in 2016 and 
its lowest frequency was 32 (16.3%) in 1996. There was also a significant difference in the 
frequency of gastrointestinal cancers in different studied years (p <0.001). 
Conclusion: The trends in the incidence of stomach and colorectal cancers in northern Iran 
were increasing while esophageal cancer was decreasing. 
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Cancer is a worldwide major problem (1-3) with a considerable economic burden on 
countries (4, 5). The change in trends of cancer incidence and its rate heavily depends on 
changes in life-environmental risk factors, the methods of preparing and producing food 
material, genetic differences and cultural and socio-economic conditions (6-9). The rapid 
change in these patterns results in the epidemiology of cancers (7, 9). 25 out of every 
thousand people suffer from cancer in Iran(10), Some studies showed that the incidence of 
some cancers is increasing and that of others is decreasing worldwide (11). 
Gastrointestinal cancer is one of most prevalent cancers worldwide (12-14) with the 
highest mortality rate and its incidence is different in the world, especially Asian regions 
(15). The most incident gastrointestinal cancers with high mortality rates include Stomach, 
Esophagus and Colorectal cancers (16), their incident rates are different (17, 18). The trend 
of incidence of stomach cancer is decreasing worldwide (19-22). In European countries, 
the incidence of esophageal cancer is increasing and so is colorectal cancer among 
individuals with <50 years old; however, stomach cancer incidence is in decreasing rate 
(23-26). In Asian regions, the incident trends of Stomach, Esophageal and Colorectal 
cancers are in increasing rates with very different epidemiology (27). Siegel et al. found 
that the incidence of colorectal cancer was in increasing rate in the USA (16) and Joliet et 
al. reported a similar trend in gastric cancer in Switzerland (23). Based on some studies on 
cancer incidence among Iranian men and women, the incidence of gastrointestinal tract 
cancers, as the most prevalent cancers after breast cancer, is increasing (28, 29). 
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Baniasadi et al. found the increased incidence of 
colorectal cancer in Southeast Iran during the past decade 
(30). In Eastern Azerbaijan, the incidence of colorectal 
cancer is on the rise, but esophageal cancer is declining (31). 
Cancer is the second most common cause of non-accidental 
deaths in Iran (32-34). Having appropriate information on 
trends of cancers is necessary for estimating their economic 
burden (4). This can help in resource management, resource 
priorities and cost evaluation for future prevention, treatment 
and screening those at risk (35, 36). Having this in mind and 
considering the importance of cancer statistics, trends and its 
incidence and mortality rates and patterns, this study aimed 
at investigating the pattern of gastrointestinal cancers in 
northern Iran during 1991-2016.  
 
 
Methods   
This research is a trend analysis. Research population 
included cancer patients referring to Shahid Rajai Hospital in 
Babolsar, northern Iran, as the only center for radiotherapy in 
the north of Iran. A multi-staged random sampling method 
was used for sampling. At first, studied years were 
determined by applying a systematic random sampling with 
the coefficient of five (years 1991, 1996, 2001, 2006, 2011, 
2016) for a 25-year period. Then, all 1535 patients referring 
to the center for the first time for radiotherapy or 
chemotherapy in the selected years were included in the study. 
Data collection instrument was a researcher-made checklist 
validated by consulting 8 professionals. The checklist included 
information such as patient’s first name and family name, 
gender, occupation, marital status, the city or state of residence, 
and either in urban or rural regions. The protocol of study 
was approved by the Ethics Committees of Babol University 
of Medical Sciences and Sari Islamic Azad University 
(IR.IAU.SARI.REC.1396.39). Data were collected from the 
archived records and the hospital health information management 
system. Data were analyzed by SPSS Version 22, using the t-
test, χ2 and ANOVA in the significant level of ≤0.05.  
 
 
Results 
The total number of patients who referred to the center 
for the first time in the studied years was 1535. Their mean 
ages of those who firstly develop esophageal cancer, gastric 
cancer and colorectal cancer were 64.9±13.11, 60.66±12.78 
and 55.96±14.80 years old, respectively. There was a 
significant relationship between the kind of gastrointestinal 
cancers and age (p<0.001). The most frequent cancer among 
male and female patients was esophageal cancer with 256 
(44.2%) and 372 (39%), respectively (table 1). 
Table 1. The states of cancer patients based on their 
demographic and background variables 
Variable      
Esophageal  
N=628 
N (%) 
Stomach 
N=464 
N (%) 
Colorectal  
N=443 
N (%) 
P value 
Male 
Female 
256(44.2) 
 372(39) 
144(24.8) 
320(33.5) 
180(31) 
263(27.5) 0.002 
Urban 
Rural 
829(37.2) 
330(33) 
248(30.9) 
216(29.5) 
256(31.9) 
187(25.5) 0.003 
1991 
1996 
2001 
2006 
2011 
2016 
137(56.1) 
117(59.7) 
110(53.7) 
96(34.8) 
90(28.4) 
78(26.3) 
67(27.5) 
47(24.0) 
44(21.5) 
85(30.8) 
111(35.0) 
110(37.0) 
40(16.4) 
32(16.3) 
51(24.9) 
95(34.4) 
109(36.7) 
109(36.7) 
<0.001 
 
As table 2 shows, the overall mean age of the patients 
was 61.03±14.01, with the highest and lowest means of 
57.84±13.81 in 1991 and of 63.83±14.12 in 2016, 
respectively. The mean age rates of patients were 
significantly different in various years with an increasing 
trend in time (p<0.001).  
Table 2. The mean age rates of studied cancer patients during 1991-2016 
Year Case SD ±Mean 
95% Confidence Interval for Mean 
Minimum 
Maximum 
Lower Bound Upper Bound 
1991 244 13.81   ± 57.84 56.10 59.58 6 94 
1996 195 59.85±14.96 57.74 61.97 9 90 
2001 204 61.11±13.87 59.19 63.02 26 90 
2006 276 61.86±13.75 60.23 63.48 20 89 
2011 317 60.84±13.27 59.38 62.31 22 88 
2016 297 63.83±14.12 62.22 65.44 11 91 
Total 1533 61.03±14.01 60.33 61.74 6 94 
                  P=0.001  
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Figure 1 shows the incidence rates of gastrointestinal 
cancers among the patients in the selected years. As it can be 
seen, the patterns of stomach and colorectal cancers showed 
an increasing trend. The pattern of esophageal cancer, 
however, showed a decreasing mode. Also, the highest 
incidence of stomach cancer was reported 111 (35%) in 2011 
and the lowest frequency was 44 (16.3%) in 1996, The 
highest frequency of esophageal cancer was reported to be 
137 (56.1%) in 1991 and the lowest frequency was 78 
(26.3%) in 2016, while the highest incidence of colorectal 
cancer was 109 (36.7%) in 2016 and the lowest frequency 
was 32 (16.3%) in 1996. There was also a significant 
difference in the frequency of gastrointestinal cancers in 
different years (p <0.001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The trends of gastrointestinal cancers between 
1991-2016 based on the frequencies of patients referring 
to the hospital  
 
The trends of incidence of esophageal cancer in urban 
regions and among rural men were decreasing while for the 
rural women was increasing. However, incidence cancer 
trends of stomach and colorectal were increasing in rural and 
urban regions as well as among the rural and urban men and 
women.  
The speed of incidence of colorectal cancer in urban 
regions was more than the rural regions (figure 2). 
The mean age of those suffering from esophageal cancer 
in both male and female patients was higher (65.90±13.11) 
than that those with stomach cancer (60.66±12.78) and 
colorectal cancer (55.96±14.80), with an increasing pattern 
in all studied gastrointestinal cancers (figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. The trend of incidence of gastrointestinal 
cancers in northern Iran among the rural and urban 
regions and rural and urban men and women  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The mean age of patients referring to the 
hospital center based on the studied year, gender and 
cancer type during 1991-2016  
 
 
Discussion  
Findings showed that the trends of incidence of stomach 
and colorectal cancers in northern Iran were increasing and 
esophageal cancer was decreasing. However, the mean age 
of patients with gastrointestinal cancer decreased in the 
studied years. The incidence rate of gastrointestinal cancers 
in men was significantly higher than that of women. This is 
in line with the findings of study by Fitzmaurice in which 29 
cancer groups in the Eastern Mediterranean had been studied 
in the years 2005-2015 (35). Arnold et al. in 2015 studied the 
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incidence rate of five common cancers in European countries 
from 1998 to 2008 and found that the incidence of stomach 
cancer among men was higher than the women, but with 
similar trends in the incidence of rectum and colon cancers 
in men and women (20).  
The incidence of esophageal cancer in this study had a 
decreasing trend. This cancer is more prevalent in Asia (37), 
especially in northern Iran (29). In addition, the rate of its 
incidence among men was higher than the women and the 
older ones suffered more from it. Joliet et al. found a similar 
trend in the incidence of gastrointestinal cancers in 
Switzerland with that of other European countries, where the 
incidence of esophageal and colorectal cancers was in a 
considerable increasing trend and stomach cancer was in a 
decreasing trend (23).  
The incidence of esophageal and gastric cancers in the 
United States in 1997-2014 has been examined and the 
findings have shown that the incidence of esophageal cancer 
in the country has been declining (38). The incidence of 
esophageal cancer and its relation with human development 
indicators in 41 countries, including Asian countries showed 
that the incidence of this cancer is in a decreasing trend, 
possibly due to changes in lifestyles, population settings and 
food consumption patterns as well as epidemiological 
phenomena (39).  
Other studies showed that the incidence of esophageal 
cancer in different regions has different decreasing-
increasing trends (40-42), possibly due to various lifestyles 
in the world. In the present study, the incidence of 
esophageal cancer has increased with increasing age, and 
Thrift's study in the United States and Sweden has also 
shown an increase in age-related esophageal cancers (43). 
Our findings showed that the incidence trend of stomach 
cancer with a higher rate in Eastern Asia (27) is increasing 
with a slower slope than that of colorectal cancer in northern 
Iran. Its incidence was higher in urban regions than the rural 
areas. Jemal et al. reported a decreased trend in stomach 
cancer worldwide (7).  
Stating that the pattern of cancer incident is different 
worldwide and related to human development indicators, 
Vineis et al. reported a decreasing trend in the incidence of 
stomach cancer worldwide (1).  
Arnold et al. reported that the incidence of stomach 
cancers in European countries was in a decreased pattern, 
mainly due to decreased infection with H.pylori as the main 
factor of stomach cancer (20).  
The incidence trend of stomach cancer in some Asian 
countries, such as Japan, China, Colombia, Ukraine and 
Russia was reported as in a decreasing trend, due to less 
dependence on salty food and more use of fresh vegetables 
and fruits (7). This is not the case of our finding, possibly 
due to administering a comprehensive program for screening 
and preventing cancers as well as controlling H.pylori in 
these Asian countries other than Iran. Another possible 
reason is the difference in dietary intake and the use of more 
agricultural pesticides in northern Iran. 
Our study showed that the incidence rate of colorectal 
cancer with the highest incidence rate in Eastern Asia and 
Europe (20) is in a speedy trend in northern Iran in 
comparison with other gastrointestinal cancers. Ferlay et al 
reported that this cancer is more common worldwide (9) and 
its incidence varies widely across regions of the world, 
reflecting socio-economic development and rising in 
countries such as Russia, China and Brazil, Canada, the 
United Kingdom, Denmark and Singapore (44). This cancer 
is more common in regions with high human development 
indicators comparing with those with moderate human 
development indicators, where stomach cancer is more 
common (11).  
Arnold et al. found colorectal cancer as one of the four 
common cancers in European countries with an increasing 
trend in its incidence (20). The increasing trend in the 
incidence of colorectal cancer can be a sign of dietary pattern 
and lifestyle changes worldwide (7, 20). Similar studies were 
conducted in northeastern Iran 2007-2011 (2) and southeast 
of Iran during 2003-2013 (30), and the results indicate an 
upward trend in colorectal cancer in these areas. 
As another finding, the highest incidence of colorectal 
cancer belonged to urban regions, conformed the argument 
by Olrich et al. showing a significant relationship between 
the incidence of colorectal cancer and dietary patterns (17). 
It appears that the higher incidence of colorectal cancer in 
urban population results from changes in their dietary 
patterns and the use of more synthesized food.  
In conclusion, the incidence of esophageal cancer in 
northern Iran was in a decreasing trend stomach and 
colorectal cancers were in increasing trends. The trends can 
be appropriately managed by making regular screening 
programs, promotion of community health level, increasing 
public awareness about cancer and its symptoms, decreasing 
risky behaviors closely associated with cancer incidence as 
well as controlling H.pylori, fatness, and changing lifestyle.  
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